UPDATE: Bed Bath & Beyond (BBBY) PT Raised to $22 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bed Bath & Beyond (BBBY) PT Lowered to $22 as KeyBanc Expects Continued Underperformance
April 15, 2021 7:12 AM EDTKeyBanc analyst Bradley Thomas lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $22.00 (from $24.00) while maintaining a Underweight rating after the company reported 4Q adjusted EPS of $0.40, above the consensus of $0.31, driven primarily by a greater than expected decrease in SG&A expenses. Total enterprise sales... More
Bed Bath & Beyond (BBBY) PT Lowered to $27 at Wedbush
April 15, 2021 6:40 AM EDTWedbush analyst Seth Basham lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $27.00 (from $33.00) while maintaining a Neutral rating.... More
Baird Reiterates Neutral Rating on Bed Bath & Beyond (BBBY), Will Monitor Turnaround Story
April 15, 2021 6:27 AM EDTBaird analyst Peter S. Benedict reiterated a Neutral on Bed Bath & Beyond (NASDAQ: BBBY)
The analyst comments "4Q results were better than expected, and FY21 guidance was reiterated. That said, 1Q's adjusted EBITDA outlook was light, and store traffic/comps remain under... More
Bed Bath & Beyond (BBBY) PT Lowered to $30 at Telsey
April 15, 2021 5:19 AM EDTTelsey analyst Cristina Fernandez lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $30.00 (from $40.00) while maintaining a Market Perform rating.... More
Increasing unusual put option volume: ERIC BBBY
April 14, 2021 10:33 AM EDTIncreasing unusual put option volume: ERIC BBBY
... MorePre-Open Stock Movers 04/14: (GALT) (MBRX) (IDEX) Higher; (BBBY) (MFH) (DISCK) Lower (more...)
April 14, 2021 9:23 AM EDTToday's Pre-Open Stock Movers:
Galectin Therapeutics Inc. (NASDAQ: GALT) 33% HIGHER; announced that a paper published in the peer-reviewed Journal for ImmunoTherapy of Cancer (JITC), the highest ranked fully open access immunology journal, provides further clinical evidence that using belapectin, a potent galectin-3 inhibitor, in combination with pembrolizumab (KEYTRUDA®), a PD-1 inhibitor, significantly enhances tumor response to immunotherapy in patients with advanced metastatic melanoma (MM) and head and neck squamous cell carcinoma (HNSCC).
Bed Bath & Beyond (BBBY) Tops Q4 EPS by 9c, Reaffirms Outlook
April 14, 2021 7:02 AM EDTBed Bath & Beyond (NASDAQ: BBBY) reported Q4 EPS of $0.40, $0.09 better than the analyst estimate of $0.31. Revenue for the quarter came in at $2.62 billion versus the consensus estimate of $2.63 billion.
3rd Consecutive Quarter of Comparable Sales Growth+4% Comp Sales growth on Total Enterprise, including digital comp growth of... MoreBed Bath & Beyond (BBBY) call put ratio 1 call to 1.5 puts into quarter release and outlook
April 13, 2021 3:53 PM EDTBed Bath & Beyond (NASDAQ: BBBY) call put ratio 1 call to 1.5 puts into quarter release and outlook
